Xeris Biopharma Holdings Inc

0.06 (2.34%)
Stock Name Stock Symbol Market Stock Type
Xeris Biopharma Holdings Inc XERS NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
0.06 2.34% 2.62 06:30:00
Open Price Low Price High Price Close Price Previous Close
2.56 2.52 2.655 2.62 2.56
more quote information »

Recent News

Date Time Source Heading
01/6/202321:00BWXeris Biopharma to Participate at the Jefferies Healthcare..
10/5/202306:38EDGARQuarterly Report (10-q)
09/5/202321:21EDGARCurrent Report Filing (8-k)
09/5/202321:00BWXeris Biopharma Reports First Quarter 2023 Financial Results
02/5/202321:00BWXeris Biopharma to Report First Quarter 2023 Financial..
27/4/202306:31EDGARAnnual Report to Security Holders (ars)
27/4/202306:24EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
27/4/202306:15EDGARProxy Statement (definitive) (def 14a)
18/4/202321:00BWXeris Biopharma Announces Issuance of U.S. Patent Covering..
30/3/202322:00BWXeris Biopharma Announces Research Evaluation Collaboration..
30/3/202307:55EDGARStatement of Changes in Beneficial Ownership (4)
30/3/202307:15EDGARCurrent Report Filing (8-k)
30/3/202307:05BWXeris Biopharma Appoints Ricki Fairley to Board of Directors
09/3/202308:29EDGARSecurities Registration: Employee Benefit Plan (s-8)
08/3/202323:21EDGARCurrent Report Filing (8-k)
08/3/202322:00BWXeris Biopharma Reports Fourth Quarter and Full-Year 2022..
23/2/202323:00BWXeris Biopharma to Report Fourth Quarter and Full-Year 2022..
15/2/202304:15EDGARAmended Statement of Ownership (sc 13g/a)
11/2/202301:05EDGARStatement of Ownership (sc 13g)
02/2/202323:00BWXeris Biopharma to Participate in the SVB Securities Global..
02/2/202308:14EDGARStatement of Changes in Beneficial Ownership (4)
02/2/202308:14EDGARStatement of Changes in Beneficial Ownership (4)
30/1/202323:58DJNXeris Biopharma Gets Orphan-Drug Exclusivity for Recorlev
30/1/202323:00BWXeris Biopharma Announces FDA Grants Orphan-drug Exclusivity..
21/1/202308:13EDGARCurrent Report Filing (8-k)
06/1/202308:03BWXeris Biopharma to Present at 41st Annual J.P. Morgan..
05/1/202323:04EDGARCurrent Report Filing (8-k)
05/1/202323:00BWXeris Biopharma Updates Its Outlook For 2022
15/12/202223:00BWXeris Biopharma Announces Plans for a Phase II Dose-Finding..
15/12/202208:11EDGARStatement of Changes in Beneficial Ownership (4)
23/11/202222:00BWXeris Biopharma Announces Research Collaboration and Option..
14/11/202214:56TRMNSVB Securities Reaffirms Their Buy Rating on Xeris..
10/11/202222:30TRMNAnalysts Offer Insights on Healthcare Companies: Celldex..
10/11/202208:35EDGARQuarterly Report (10-q)
09/11/202223:00BWXeris Biopharma Reports Third Quarter 2022 Financial Results..
02/11/202222:00BWXeris Biopharma to Report Third Quarter 2022 Financial..
01/11/202222:00BWXeris Biopharma Announces Results of the Extended Evaluation..
27/10/202206:50TRMNAnalysts Offer Insights on Healthcare Companies: Revance..
20/10/202223:21EDGARCurrent Report Filing (8-k)
20/10/202221:00BWXeris Biopharma Announces Positive Topline Phase 1 Clinical..
04/10/202207:04EDGARCurrent Report Filing (8-k)
11/9/202219:15TRMNSVB Securities Keeps Their Buy Rating on Xeris..
11/8/202220:25TRMNH.C. Wainwright Reaffirms Their Buy Rating on Xeris..
11/8/202206:18EDGARQuarterly Report (10-q)
10/8/202221:07EDGARCurrent Report Filing (8-k)
10/8/202221:00BWXeris Biopharma Reports Second Quarter Financial Results and..
03/8/202221:30BWXeris Biopharma to Report Second Quarter 2022 Financial..
01/8/202221:30BWXeris’ Commercialization Partner for Ogluo®, Tetris Pharma..
25/7/202219:22TRMNSVB Securities Thinks Xeris Pharmaceuticals’ Stock is Going..
04/7/202212:43TRMNSVB Securities Thinks Xeris Pharmaceuticals’ Stock is Going..
Your Recent History
Xeris Biop..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: D: 20230602 02:21:05